Advanced search
Publication Cover
Journal of Medical Economics Volume 16, 2013 - Issue 5
Submit an article Journal homepage
551
Views
6
CrossRef citations to date
0
Altmetric
Original Articles

Cost-utility of pregabalin as add-on to usual care versus usual care alone in the management of peripheral neuropathic pain in Belgium

Pierre ChevalierIMS Health HEOR BrusselsBelgiumCorrespondence[email protected]
,
Mark LamotteIMS Health HEOR BrusselsBelgium
,
Hilde Van CampenhoutPfizer BrusselsBelgium
,
Roman EyckermanPfizer BrusselsBelgium
&
Lieven AnnemansI-CHER, Ghent University, Brussels University (VUB) GhentBelgium
Pages 596-605 | Accepted 28 Jan 2013, Published online: 04 Mar 2013

Citations (6)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Simone Critchlow, Matthew Hirst, Ron Akehurst, Ceri Phillips, Zoe Philips, Will Sullivan & Will C.N. Dunlop. (2017) A systematic review of cost-effectiveness modeling of pharmaceutical therapies in neuropathic pain: variation in practice, key challenges, and recommendations for the future. Journal of Medical Economics 20:2, pages 129-139.
Read now
Ataru Igarashi, Manabu Akazawa, Tatsunori Murata, Toshihiko Taguchi, Alesia Sadosky, Nozomi Ebata, Richard Willke, Koichi Fujii, Jim Doherty & Makoto Kobayashi. (2015) Cost-effectiveness analysis of pregabalin for treatment of chronic low back pain in patients with accompanying lower limb pain (neuropathic component) in Japan. ClinicoEconomics and Outcomes Research 7, pages 505-520.
Read now

Articles from other publishers (4)

Natalia Ruiz-Negrón, Jyothi Menon, Jordan B. King, Junjie Ma & Brandon K. Bellows. (2019) Cost-Effectiveness of Treatment Options for Neuropathic Pain: a Systematic Review. PharmacoEconomics 37:5, pages 669-688.
Crossref
Antoni Sicras-Mainar, Javier Rejas-Gutiérrez, Maria Perez-Paramo & Ruth Navarro-Artieda. (2018) Cost of treating peripheral neuropathic pain with pregabalin or gabapentin at therapeutic doses in routine practice. Journal of Comparative Effectiveness Research 7:7, pages 615-625.
Crossref
Antoni Sicras‐Mainar, Javier Rejas‐Gutiérrez, María Pérez‐Páramo & Ruth Navarro‐Artieda. (2016) Cost of treatment of peripheral neuropathic pain with pregabalin or gabapentin in routine clinical practice: impact of their loss of exclusivity. Journal of Evaluation in Clinical Practice 23:2, pages 402-412.
Crossref
Lieven Annemans, Johanne Silvain & Gilles Montalescot. (2015) Cost-Effectiveness of a Novel Self-Apposing Stent in ST-Segment Elevation Myocardial Infarction (STEMI) in France. EMJ Cardiology, pages 22-29.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.